Eczema and Doxycycline


Eczema Symptoms and Causes

Eczema is a term for several different types of skin swelling. Eczema is also called dermatitis. Most types cause dry, itchy skin and rashes on the face, inside the elbows and behind the knees, and on the hands and feet. Scratching the skin can cause it to turn red, and to swell and itch even more.

Eczema is not contagious. The cause is not known. It is likely caused by both genetic and environmental factors. Eczema may get better or worse over time, but it is often a long-lasting disease. People who have it may also develop hay fever and asthma.

The most common type of Eczema is atopic dermatitis. It is most common in babies and children but adults can have it too. As children who have atopic dermatitis grow older, this problem may get better or go away. But sometimes the skin may stay dry and get irritated easily.

Treatments may include medicines, skin creams, light therapy, and good skin care. You can prevent some types of Eczema by avoiding

  • Things that irritate your skin, such as certain soaps, fabrics, and lotions
  • Stress
  • Things you are allergic to, such as food, pollen, and animals

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Check out the latest treatments for eczema

eczema treatment research studies

Doxycycline clinical trials, surveys and public health registries

Find Drug Side Effect reports

Doxycycline Side Effects

Headache (186)
Nausea (176)
Rash (131)
Dizziness (126)
Vomiting (125)
Dyspnoea (125)
Pain (125)
Haemorrhage (116)
Malaise (114)
Diarrhoea (111)
Oesophageal Ulcer (100)
Pyrexia (97)
Fatigue (95)
Chest Pain (95)
Anxiety (94)
Pruritus (92)
Abortion Incomplete (91)
Photosensitivity Reaction (88)
Asthenia (82)
Abdominal Pain Upper (71)
Depression (41)
Abdominal Pain (40)
Anaemia (38)
Stevens-johnson Syndrome (35)
Suicidal Ideation (34)
Muscle Spasms (32)
Confusional State (32)
Vision Blurred (31)
Oesophagitis (31)
Oedema Peripheral (31)
Dyspepsia (30)
Hypotension (30)
Pancreatitis (30)
Syncope (30)
Benign Intracranial Hypertension (29)
Paraesthesia (28)
Palpitations (28)
Arthralgia (27)
Erythema (27)
Visual Impairment (27)
Intracranial Pressure Increased (27)
Pulmonary Embolism (27)
Dysphagia (26)
Blister (26)
Abdominal Discomfort (25)
Pancreatitis Acute (25)
Renal Failure Acute (25)
Panic Attack (25)
Hypersensitivity (24)
Swollen Tongue (24)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

I am 11 days into a 20 day regime of Doxycycline for Staph. I am 51 and have not had a period in 2 years. 2 days ago I had some breast tenderness and this morning I woke to classic menstrual bleeding with abdominal cramps. Could the Doxycyclin

I am a 45 year old women who developed acne 4 years agao after my hysterectomy.Ihave been using doxycycline for the last 10 months......the only side effects I have experienced are nausea if pill tkn in empty stomach and weight gain ( which

I am anaemic and i've been treating my acne with doxycycline but instead my anaemia got worse i'm drowzy,my head feels heavy and i have a headache from hell.

I had these 100mg tablets for a sinus infection its gone now i take the last 1 tomorrow but after the few few days on them i ad to take 8 2 to start with then 1 a day. so after a few days on them i got 2 complaints my anus was a bit sore and neck an

I have just taken myself off Doxycycline. I had so much pressure in my skull - unable to stand for very long, felt really weak and thought I was going to pass out..A Few pains in my kidney area.

I need help, i just got eczema e few months ago, and i m 21 years old it is at my feet, i doesn't feel itchi but it spreading slowly, what should i apply to cure it?

I took doxycycline for 10 days for perioral dermatitis. A week after completing the medicine I went to the ER with a burning in my chest. Then I lost my appetite, was nauseousand started losing weight. Three weeks later I was diagnosed with

I was taking doxycycline for an MRSA staph infection. I had tightness in my chest and worsening difficulty breathing, sore tongue, burning palms and soles of my feet, and extreme exhaustion. At the end of my 9th day on the medication, I had excruti

I was taking doxycycline for meibomitis and a little over 2 weeks after I started I came ill with severe head pressure,tinnitus,chills,nausea,flulike symptoms and after 2 emergency room visits and 6 different doctors (who were trying to treat me for

I was taking them as an anti-malarial. Caused a duodenal ulcer and a bleed on the brain, either of which could have killed me. Both nearly did, I had 3 months in hospital and 8 operations before I was discharged. I will probably never be properly wel

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

I am 67 and I was precribed Diamicron MR 30mg capsules for two years, recently I was prescribed Proscar for prostate BPH then I developed severe eczema I stopped taking Proscar immediately and now I can not take diamicro MR any more because it give

I am of 53 suffering with skin problem for several years. Doctors are unable to diagnose the exact problem. Some doctors say it is Urticaria, some say it is some sort of Eczema and so on. The currentphysician advised to

Broken sleep..reduced to 4-5 hours in total Awareness of heart beating quite strongly in the night or when sitting reading knitting etc. Dry skin, eczema in ears, dry itchy eyes so unable to wear contact lenses any more Energy levels soon run down wh

Clobex worked great on a patch of eczema I've had for four years, in two weeks it cleared up and is still gone. However, I experienced racing heart, palpitations and dypsnea. These have not subsided despite not using Clobex for two weeks.

I am 20 and i have eczema i used to use tavegyl from avery small age till 17 on regular basis is it okay to do so??

I am of 53 suffering with skin problem for several years. Doctors are unable to diagnose the exact problem. Some doctors say it is Urticaria, some say it is some sort of Eczema and so on. The currentphysician advised to take RONEX(Cetirizin

I have been taking amoxicillin for dental reasons, being an eczema sufferer on my scalp area the last two times i have had to use amoxicillin my scalp has become severly inflamed and infected ending up in having to take different antibiotics to clear

I need help, i just got eczema e few months ago, and i m 21 years old it is at my feet, i doesn't feel itchi but it spreading slowly, what should i apply to cure it?

I recently moved (incredibly stressful) and hey-presto, got eczema for the first time ever. I was in agony, trying to scratch my skin off my bones and covered in blisters. I started taking Telfast and it has disappeared! So far (1 week) no side ef

Eczema Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Group Eczema Education Visits:Impact on Patient and Family Quality of Life
Condition: Eczema
Interventions: Other: Group Eczema education session;   Other: Control group
Outcome Measures: The difference between the two groups in CADIS score;   Assess extent of skin disease.;   Assess average monthly number of follow-up phone calls.;   Assess average monthly number of urgent and emergency visits.
2 Unknown  Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema
Conditions: Vesicular Palmoplantar Eczema;   Pompholyx
Intervention: Drug: dandelion juice
Outcome Measures: Improvement in dyshidrotic hand Eczema in the study period assessed by HECSI score.;   Improvement in dyshidrotic Eczema in the study period assessed by the patient (Visual Analog Scale).
3 Unknown  A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema
Conditions: Eczema;   Dermatitis;   Skin Disease
Intervention: Behavioral: A randomised clinical trial of the effect of classification and individual counselling
Outcome Measures: Primary outcome: Objective assessment of disease severity (HE), measured by HECSI-score at time = 6 months versus HECSI-score at time = 0.;   Secondary outcomes: -Subjective assessment of disease severity (HE) -Number of eruptions through the past three months -Knowledge of skin protection -Skinprotective behaviour -Quality of life
4 Unknown  Chronic Hand Eczema - Self-management and Prognosis
Conditions: Chronic Hand Eczema;   Chronic Hand Dermatitis
Intervention: Behavioral: Healthy Skin Clinic
Outcome Measures: Hand Eczema Severity Index (HECSI);   Dermatology Life Quality Index (DLQI);   Overall burden of disease (VAS);   Danish version of The Medication Adherence Report Scale (DMARS-4);   Number of eruptions through the last six months
5 Recruiting Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Outcome Measures: Expression of Interferon (IFN) and Interleukin (IL-12), in response to stimulation with Herpes Simplex Virus 1 (HSV-1), Vaccinia Virus (VV), and Pattern Recognition Receptors (PRR) agonists.;   Cell surface expression of Major Histocompatibility complex (MHC) class I/II and co-stimulatory molecules on CD14+ cells in response to IFN-γ and IFN-α stimulation.;   Production of IL-18 and IFN-α protein and mRNA by CD14+ cells following stimulation with HSV-1, VV, or PRR agonists.;   Production of IFN-γ protein by CD8+ T cells in response to stimulation with recombinant human cytokines including but not limited to IL-12, IL-18, and IFN-α.;   Protein expression of IFN-γ receptor and IFN- α/β receptor on CD14+ cells.;   Immunodominant HSV-1 peptide repertoires.;   High-throughput gene expression profiling to analyze ribonucleic acid (RNA) from HSV-1 stimulated and sham stimulated CD14+ monocytes.;   Production of protein and RNA of IFN family members and any related pro- or anti-inflammatory cytokines/chemokines in response to stimulation of PBMCs or purified monocytes;   Expression of MHC and co-stimulatory molecules on CD14+ cells in response to stimulation with HSV-1, VV, or PRR agonists.;   Viral titer of VV as determined by plaque assay following incubation of virus with PBMCs.;   Gene expression profiles and gene variant profiles of PBMCs stimulated with HSV-1 as assayed by RNA-seq.
6 Recruiting Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
Conditions: Dermatitis, Atopic;   Eczema, Atopic
Interventions: Drug: Tofacitinib ointment 20mg/g;   Drug: Placebo ointment (Vehicle)
Outcome Measures: Eczema Area and Severity Index (EASI);   Physician Global Assessment (PGA) of Disease Activity;   Body surface ares (BSA);   Eczema area and severity index (EASI) clinical sign severity sum score
7 Recruiting A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema
Conditions: Eczema;   Skin Conditions
Intervention: Behavioral: group education
Outcome Measures: Sick leave;   Health-related quality of life;   Disease severity;   Eczema-related sick leave
8 Recruiting Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment
Condition: Eczema
Interventions: Drug: Group 1;   Drug: Group 2
Outcome Measures: Reduction / improvement of signs and symptoms;   Adverse Events Evaluation
9 Recruiting Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
Condition: Mild to Moderate Atopic Dermatitis
Interventions: Drug: SB011, 2 % (Water/Oil/Water) emulsion of hgd40;   Drug: Multiple W/O/W formulation, active ingredient-free vehicle
Outcome Measures: Change of local SCORing atopic dermatitis (SCORAD) from baseline to Day 15.;   The change from baseline in modified local SCORAD;   Modified local SCORAD;   Change from baseline in transepidermal water loss (TEWL);   TEWL on Days 1, 3, 5, 8, 12, and 15;   Subjective assessment of pruritus using a 10-point rating scale;   Subjective efficacy assessment on Days 3, 5, 8, 12 and 15;   Subjective dermal tolerability assessment using a 5-point rating scale on Days 3, 5, 8, 12 and 15;   Pharmacokinetic outcome measure;   Physical examination of the skin and Vital signs;   Adverse Events;   Standard Safety laboratory
10 Recruiting A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
Conditions: Eczema;   Atopic Dermatitis
Outcome Measures: Improvement in Health of Skin;   Patient satisfaction;   Decreased itching;   Reduction of bacteria
11 Recruiting Registry for the Atopic Dermatitis Research Network
Conditions: Atopic Dermatitis;   Eczema Herpeticum
Outcome Measures: Genotype and sequence data from ADEH+ and ADEH- participants.;   Genotype and sequence data from ADEH- participants with and without bacterial colonization with S. aureus.;   Single Nucleotide Polymorphism (SNP) and Copy Number Variant (CNV) genotype data for candidate genes, including but not limited to Claudin-1 (CLDN1) and Filaggrin (FLG).;   SNP genotype data for candidate genes, including but not limited to CLDN1 and FLG, validated in samples from an independent AD population.;   Targeted deep resequencing of candidate genes, including but not limited to CLDN1.;   Analysis of S. aureus isolates for antibiotic sensitivity;   Analysis of S. aureus isolates for SCC mec DNA elements.;   Analysis of S. aureus isolates for expression of virulence or other factors.;   Expression of biomarkers, including but not limited to serum biomarkers, among AD sub-phenotypes.;   Analysis of microbial composition by 16S rDNA amplicon sequencing.;   Analysis of DNA methylation profiles;   Analysis of mRNA expression profiles in whole blood samples.;   Frequency of commensal Staphylococcus species producing antimicrobial activity
12 Recruiting The Effects of Emollient Therapy on the Skin Barrier
Conditions: Atopic Dermatitis;   Eczema
Interventions: Other: Pediatric Moisturizer;   Other: Adult Moisturizer
Outcome Measure: Number of participants with improved skin barrier function as a result of emollient use
13 Recruiting Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Conditions: Atopic Dermatitis;   Eczema;   Ichthyosis Vulgaris
Outcome Measures: Identify skin bacterial diversity;   Exploration of common and rare microflora species that reside on human skin in normal and disease state
14 Recruiting A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
Conditions: Eczema;   Hand Eczema;   Atopic Dermatitis
Interventions: Other: CLn BodyWash;   Other: Cetaphil Daily Facial Cleanser
Outcome Measure: Change in Amount of Skin Fauna
15 Recruiting Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction
Conditions: Allergy;   Eczema;   Respiratory Tract Infections
Intervention: Biological: BCG
Outcome Measures: Prevalence of positive skin prick tests;   Prevalence of Eczema;   Prevalence of lower respiratory tract infections;   Prevalence and severity of challenge-proven food allergy in study participants with a positive SPT;   Prevalence of hospital admissions for respiratory illness;   Other measures of infection including febrile episodes;   Laboratory measures of the immune response;   Severity of Eczema
16 Unknown  Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
Condition: Eczema
Intervention: Drug: Topical B12 0.07%
Outcome Measure: Reduction in SCORAD at 2 and 4 weeks
17 Not yet recruiting Investigating Immune Mechanisms in Atopic Eczema
Condition: Atopic Dermatitis
Interventions: Procedure: Skin biopsy;   Procedure: Skin suction blister;   Biological: Mantoux test
Outcome Measure: Number of regulatory T cells in lesional skin of atopic dermatitis patients compared to healthy volunteers
18 Recruiting Defining the Unique Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema
Outcome Measures: Cellular infiltrates;   Gene expression;   Correlation of biomarkers to quality of life
19 Unknown  Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
Conditions: Impetigo;   Folliculitis;   Secondarily Infected Eczema;   Minor Soft Tissue Infections
Intervention: Drug: Retapamulin (Altabax)
Outcome Measure: The percentage of study participants whose wound cultures were positive for MRSA who are determined to be a clinical success at the follow-up visit.
20 Recruiting Effects of Treatments on Atopic Dermatitis
Conditions: Dermatitis, Atopic;   Human Volunteers;   Eczema;   Atopic Dermatitis
Interventions: Drug: Trimethoprim/sulfamethoxazole;   Drug: Cephalexin;   Drug: Doxycycline;   Other: Sodium hypochlorite (bleach)
Outcome Measures: To characterize microbiome alterations in healthy adult volunteers (Cohorts 1 and 2) and pediatric patients with AD and associated active bacterial infection (Cohort 3) after treatment.;   To obtain samples from healthy adult volunteers to evaluate and refine genomic analysis of human microbes. To examine how different treatments may alter the human microbiome.